Tff Pharmaceuticals Stock Analysis
TFFP Stock | USD 2.27 0.36 18.85% |
Tff Pharmaceuticals is undervalued with Real Value of 3.4 and Target Price of 7.25. The main objective of Tff Pharmaceuticals stock analysis is to determine its intrinsic value, which is an estimate of what Tff Pharmaceuticals is worth, separate from its market price. There are two main types of Tff Pharmaceuticals' stock analysis: fundamental analysis and technical analysis.
The Tff Pharmaceuticals stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Tff Pharmaceuticals is usually not traded on Memorial Day, Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday. Tff Stock trading window is adjusted to America/New York timezone.
Tff |
Tff Stock Analysis Notes
About 22.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.34. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Tff Pharmaceuticals recorded a loss per share of 6.88. The entity had not issued any dividends in recent years. The firm had 1:25 split on the 19th of December 2023. TFF Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing technology platform in the United States and Australia. The company was incorporated in 2018 and is based in Austin, Texas. Tff Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. To find out more about Tff Pharmaceuticals contact Glenn Mattes at 817 438 6168 or learn more at https://tffpharma.com.Tff Pharmaceuticals Investment Alerts
Tff Pharmaceuticals had very high historical volatility over the last 90 days | |
The company reported the previous year's revenue of 733.87 K. Net Loss for the year was (21.24 M) with loss before overhead, payroll, taxes, and interest of (21.21 M). | |
Tff Pharmaceuticals currently holds about 13.15 M in cash with (16.04 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.51. | |
Tff Pharmaceuticals has a frail financial position based on the latest SEC disclosures | |
Latest headline from zacks.com: TFF Pharmaceuticals Upgraded to Strong Buy Heres Why |
Tff Pharmaceuticals Upcoming and Recent Events
13th of February 2024 Upcoming Quarterly Report | View | |
9th of May 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
13th of February 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Tff Largest EPS Surprises
Earnings surprises can significantly impact Tff Pharmaceuticals' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2023-11-14 | 2023-09-30 | -0.11 | -0.09 | 0.02 | 18 | ||
2021-03-10 | 2020-12-31 | -0.23 | -0.26 | -0.03 | 13 | ||
2023-05-11 | 2023-03-31 | -0.23 | -0.19 | 0.04 | 17 |
Tff Pharmaceuticals Environmental, Social, and Governance (ESG) Scores
Tff Pharmaceuticals' ESG score is a quantitative measure that evaluates Tff Pharmaceuticals' performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Tff Pharmaceuticals' operations that may have significant financial implications and affect Tff Pharmaceuticals' stock price as well as guide investors towards more socially responsible investments.
Tff Pharmaceuticals Thematic Classifications
In addition to having Tff Pharmaceuticals stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
BiotechBiotechnology and pharmaceuticals production and services |
Tff Stock Institutional Investors
Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Org Partners Llc | 2024-06-30 | 740 | Ubs Group Ag | 2024-06-30 | 735 | Royal Bank Of Canada | 2024-06-30 | 156 | Raleigh Capital Management Inc. | 2024-06-30 | 91.0 | Wells Fargo & Co | 2024-06-30 | 61.0 | Hm Payson & Co | 2024-06-30 | 60.0 | Advisor Group Holdings, Inc. | 2024-06-30 | 40.0 | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 32.0 | Bank Of America Corp | 2024-06-30 | 23.0 | Carlson Capital Lp | 2024-06-30 | 293.5 K | Armistice Capital, Llc | 2024-06-30 | 185.7 K |
Tff Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 7.87 M.Tff Profitablity
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (1.77) | (1.85) | |
Return On Capital Employed | (2.36) | (2.24) | |
Return On Assets | (1.77) | (1.85) | |
Return On Equity | (2.22) | (2.11) |
Management Efficiency
Tff Pharmaceuticals has return on total asset (ROA) of (1.0591) % which means that it has lost $1.0591 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.1351) %, meaning that it created substantial loss on money invested by shareholders. Tff Pharmaceuticals' management efficiency ratios could be used to measure how well Tff Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. As of 10/12/2024, Return On Tangible Assets is likely to drop to -1.85. In addition to that, Return On Capital Employed is likely to grow to -2.24. At this time, Tff Pharmaceuticals' Total Current Liabilities is relatively stable compared to the past year. As of 10/12/2024, Liabilities And Stockholders Equity is likely to grow to about 20.7 M, while Non Current Liabilities Total is likely to drop slightly above 30.2 K.Last Reported | Projected for Next Year | ||
Book Value Per Share | 5.34 | 5.07 | |
Tangible Book Value Per Share | 5.34 | 5.07 | |
Enterprise Value Over EBITDA | (0.33) | (0.34) | |
Price Book Value Ratio | 1.32 | 1.38 | |
Enterprise Value Multiple | (0.33) | (0.34) | |
Price Fair Value | 1.32 | 1.38 | |
Enterprise Value | 7.2 M | 6.9 M |
The analysis of Tff Pharmaceuticals' management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Tff Pharmaceuticals' future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Tff Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Operating Margin (6.09) | Beta 1.36 | Return On Assets (1.06) | Return On Equity (2.14) |
Technical Drivers
As of the 12th of October 2024, Tff Pharmaceuticals has the Risk Adjusted Performance of 0.0567, coefficient of variation of 1733.46, and Semi Deviation of 6.0. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Tff Pharmaceuticals, as well as the relationship between them.Tff Pharmaceuticals Price Movement Analysis
The output start index for this execution was thirty-five with a total number of output elements of twenty-six. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Tff Pharmaceuticals middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Tff Pharmaceuticals. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Tff Pharmaceuticals Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Tff Pharmaceuticals insiders, such as employees or executives, is commonly permitted as long as it does not rely on Tff Pharmaceuticals' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Tff Pharmaceuticals insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Harlan Weisman over three months ago Acquisition by Harlan Weisman of 27480 shares of Tff Pharmaceuticals subject to Rule 16b-3 | ||
King Thomas Braxton over three months ago Acquisition by King Thomas Braxton of 1583 shares of Tff Pharmaceuticals at 1.82 subject to Rule 16b-3 | ||
Harlan Weisman over three months ago Acquisition by Harlan Weisman of 44967 shares of Tff Pharmaceuticals subject to Rule 16b-3 | ||
Rocamboli Stephen over six months ago Acquisition by Rocamboli Stephen of 43794 shares of Tff Pharmaceuticals subject to Rule 16b-3 | ||
Mills Robert S over six months ago Acquisition by Mills Robert S of 52858 shares of Tff Pharmaceuticals subject to Rule 16b-3 | ||
Mills Robert S over six months ago Exercise or conversion by Mills Robert S of 55100 shares of Tff Pharmaceuticals subject to Rule 16b-3 | ||
Mikhak Zamaneh over a year ago Purchase by Mikhak Zamaneh of 15000 shares of Tff Pharmaceuticals |
Tff Pharmaceuticals Outstanding Bonds
Tff Pharmaceuticals issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Tff Pharmaceuticals uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Tff bonds can be classified according to their maturity, which is the date when Tff Pharmaceuticals has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Dana 575 percent Corp BondUS235822AB96 | View | |
Volcan Compania Minera Corp BondUSP98047AC08 | View | |
Boeing Co 2196 Corp BondUS097023DG73 | View | |
HSBC Holdings PLC Corp BondUS404280DR76 | View | |
MPLX LP 52 Corp BondUS55336VAL45 | View | |
International Game Technology Corp BondUS460599AD57 | View | |
BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
Morgan Stanley 3591 Corp BondUS61744YAK47 | View |
Tff Pharmaceuticals Predictive Daily Indicators
Tff Pharmaceuticals intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Tff Pharmaceuticals stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Tff Pharmaceuticals Corporate Filings
10Q | 14th of August 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
8K | 6th of August 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F4 | 8th of July 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 1st of July 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
14th of June 2024 Other Reports | ViewVerify | |
8K | 7th of June 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
8K | 17th of May 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
10Q | 14th of May 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
Tff Pharmaceuticals Forecast Models
Tff Pharmaceuticals' time-series forecasting models are one of many Tff Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Tff Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Tff Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Tff Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Tff shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Tff Pharmaceuticals. By using and applying Tff Stock analysis, traders can create a robust methodology for identifying Tff entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | (26.05) | (27.35) | |
Operating Profit Margin | (27.75) | (29.14) | |
Net Loss | (26.05) | (27.35) | |
Gross Profit Margin | 0.28 | 0.26 |
Current Tff Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Tff analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Tff analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
7.25 | Buy | 1 | Odds |
Most Tff analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Tff stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Tff Pharmaceuticals, talking to its executives and customers, or listening to Tff conference calls.
Tff Stock Analysis Indicators
Tff Pharmaceuticals stock analysis indicators help investors evaluate how Tff Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Tff Pharmaceuticals shares will generate the highest return on investment. By understating and applying Tff Pharmaceuticals stock analysis, traders can identify Tff Pharmaceuticals position entry and exit signals to maximize returns.
Begin Period Cash Flow | 16.6 M | |
Common Stock Shares Outstanding | 1.8 M | |
Total Stockholder Equity | 9.6 M | |
Property Plant And Equipment Net | 2.1 M | |
Cash And Short Term Investments | 5.5 M | |
Cash | 5.5 M | |
Accounts Payable | 958.4 K | |
Net Debt | -5.4 M | |
50 Day M A | 2.0063 | |
Total Current Liabilities | 2.4 M | |
Other Operating Expenses | 22.6 M | |
Non Current Assets Total | 4.4 M | |
Non Currrent Assets Other | 2.3 M | |
Stock Based Compensation | 2.9 M |
Additional Tools for Tff Stock Analysis
When running Tff Pharmaceuticals' price analysis, check to measure Tff Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tff Pharmaceuticals is operating at the current time. Most of Tff Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Tff Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tff Pharmaceuticals' price. Additionally, you may evaluate how the addition of Tff Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.